Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) that assesses molecular diagnostic ...
For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results